Pradžia › Minkštųjų audinių sarkoma › Texas › Houston
Minkštųjų audinių sarkoma klinikiniai tyrimai Houston, TX
32 tyrimai dėl Minkštųjų audinių sarkoma ieško dalyvių vietose Houston ir aplinkui (apytiksliai 30 mylių spinduliu). Atidarykite tyrimą, kad pamatytumėte, kas gali dalyvauti ir kaip susisiekti su tyrimo komanda.
Oficialus tyrimo tekstas (anglų kalba)
Ieškote dalyvių tyrimui? Pateikite jį šio puslapio viršuje – $99 už 30 dienų →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai
- UT MD Anderson Cancer Center, Houston
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Renkami dalyviai2 fazė
- The University of Texas MD Anderson Cancer Center - Texas Medical Center, Houston
177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors
Renkami dalyviai1/2 fazė
- MD Anderson Cancer Center, Houston
Testing the Addition of an Anti-cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (Gemcitabine) for Soft Tissue Sarcoma
Renkami dalyviai1/2 fazė
- UT MD Anderson Cancer Center, Houston
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
Renkami dalyviai1/2 fazė
- Baylor College of Medicine, Houston
Anti-GD2 ADC M3554 in Advanced Solid Tumors
Renkami dalyviai1 fazė
- The University of Texas MD Anderson Cancer Center, Houston
A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors
Renkami dalyviai1 fazė
- The University of Texas MD Anderson Cancer Center, Houston
First-in-Human Study of ADCE-D01 in Soft Tissue Sarcoma
Renkami dalyviai1/2 fazė
- University Of Texas MD Anderson Cancer Center, Houston
Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
Renkami dalyviai1 fazė
- UT MD Anderson Cancer Center, Houston
Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
Renkami dalyviai1/2 fazė
- The University of Texas MD Anderson Cancer Center, Houston
Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma
Renkami dalyviai1 fazė
- UT MD Anderson Cancer Center, Houston
Actinium Therapy for Late-stage Aggressive Sarcomas
Renkami dalyviai1 fazė
- MD Anderson Cancer Center, Houston
STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas
Renkami dalyviai1/2 fazė
- MD Anderson Cancer Center, Houston
- NEXT Houston, Houston
Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program
Renkami dalyviaiStebimasis tyrimas
- M D Anderson Cancer Center, Houston
Phase 2 Trial of Zanzalintinib and Pembrolizumab in Select Subtypes of Advanced/Metastatic Soft-tissue Sarcoma
Renkami dalyviai2 fazė
- MD Anderson Cancer Center, Houston
T Cell Membrane-Anchored Tumor-Targeted IL12 -Modified TIL Cell Therapy (attIL12-TIL) for Advanced/Metastatic Soft Tissue and Bone Sarcoma Patients.
Renkami dalyviai1 fazė
- MD Anderson Cancer Center, Houston
A Study of MGC026 in Participants With Advanced Solid Tumors
Renkami dalyviai1 fazė
- The University of Texas MD Anderson Cancer Center, Houston
- University of Texas Health Science Center at Houston, Houston
Implantable Microdevice for the Delivery of Drugs and Their Effect on Tumors in Patients With Metastatic or Recurrent Sarcoma
Renkami dalyviai
- M D Anderson Cancer Center, Houston
A Phase I Study of Pazopanib in Combination With Trabectedin, Ipilimumab and Nivolumab (TraPIN) in Pediatric and Young Adult Patients With Recurrent Soft Tissue Sarcomas
Renkami dalyviai1 fazė
- The University of Texas M. D. Anderson Cancer Center, Houston
IDOV-Immune for Advanced Solid Tumors
Renkami dalyviai1 fazė
- MD Anderson Cancer Center, Houston
Prospective Study Evaluating the Treatment Outcomes for Localised Recurrent, Resectable Retroperitoneal Liposarcoma
Renkami dalyviaiStebimasis tyrimas
- MD Anderson Cancer Center, Houston
Lead-212 PSV359 Therapy for Patients With Solid Tumors
Renkami dalyviai1/2 fazė
- MD Anderson Cancer Center, Houston
Avapritinib for the Treatment of CKIT or PDGFRA Mutation-Positive Locally Advanced or Metastatic Malignant Solid Tumors
Renkami dalyviai2 fazė
- M D Anderson Cancer Center, Houston
A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors
Renkami dalyviai1 fazė
- MD Anderson Cancer Center, Houston
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
Renkami dalyviai1/2 fazė
- MD Anderson Cancer Center, Houston
Iscador® P (Mistletoe) Immunotherapy for Recurrent Resectable Osteogenic Sarcoma
Renkami dalyviai2 fazė
- M.D. Anderson Children's Cancer Hospital, Houston
SATURN-STS: Phase II Study of Neoadjuvant Atezolizumab With Doxorubicin, Concurrent Atezolizumab With Pre-operative Radiation Therapy and Adjuvant Atezolizumab in Patients With High-risk Surgically Resectable Extremity and Truncal Soft Tissue Sarcoma
Renkami dalyviai2 fazė
- The University of Texas M. D. Anderson Cancer Center, Houston
Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME Trial
Renkami dalyviai
- M D Anderson Cancer Center, Houston
Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma
Renkami dalyviai1/2 fazė
- The University of Texas MD Anderson Cancer Center, Houston
HER2 Chimeric Antigen Receptor (CAR) T Cells in Combination With Checkpoint Blockade in Patients With Advanced Sarcoma
Renkami dalyviai1 fazė
- Texas Children's Hospital, Houston
A Study of MT-4561 in Patients With Various Advanced Solid Tumors
Renkami dalyviai1/2 fazė
- The University of Texas MD Anderson Cancer Center, Houston
BostonGene and Exigent Genomic INsight Study
Renkami dalyviaiStebimasis tyrimas
- Oncology Consultants, Houston
Minkštųjų audinių sarkoma tyrimai kituose miestuose
- New York City, NY19 tyrimai
- Boston, MA18 tyrimai
- St. Louis, MO14 tyrimai
- Los Angeles, CA13 tyrimai
- Columbus, OH13 tyrimai
- Washington, DC12 tyrimai
- Memphis, TN11 tyrimai
- Philadelphia, PA10 tyrimai
- Rochester, MN9 tyrimai
- Nashville, TN9 tyrimai
- Aurora, CO9 tyrimai
- Queens, NY9 tyrimai
Kiti tyrimai Houston
- Nedidelinių ląstelių plaučių vėžys145 tyrimai
- Krūties vėžys126 tyrimai
- Vėžys (visų tipų)121 tyrimas
- Metastatinis vėžys104 tyrimai
- Storosios ir tiesiosios žarnos vėžys102 tyrimai
- Kiaušidžių vėžys89 tyrimai
- Ūmi mieloidinė leukemija85 tyrimai
- Plaučių vėžys78 tyrimai
- Prostatos vėžys76 tyrimai
- Endometrio vėžys68 tyrimai
- Kasos vėžys61 tyrimas
- Melanoma59 tyrimai
Iš ClinicalTrials.gov, duomenys gauti 2026-10-04. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.